首页> World journal of clinical cases> Relapsed/refractory classical Hodgkin lymphoma effectively treated with low-dose decitabine plus tislelizumab: A case report.

Relapsed/refractory classical Hodgkin lymphoma effectively treated with low-dose decitabine plus tislelizumab: A case report.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xiao-Sheng,Ding

第一单位： Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.

作者： Xiao-Sheng,Ding ^[1] ; Lan,Mi ^[1] ; Yu-Qin,Song ^[1] ; Wei-Ping,Liu ^[1] ; Hui,Yu ^[1] ; Ning-Jing,Lin ^[1] ; Jun,Zhu ^[2]

作者单位： Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China. ^[1] Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China. zhu-jun2017@outlook.com. ^[2]

关键词 Case report Classical Hodgkin lymphoma Hypomethylating agent Immunotherapy Survival

DOI 10.12998/wjcc.v9.i21.6041

PMID 34368325

发布时间 2021-08-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

World journal of clinical cases

2021年9卷21期

6041-6048页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

World journal of clinical cases

2021年9卷21期

6041-6048页

检索历史清除

Relapsed/refractory classical Hodgkin lymphoma effectively treated with low-dose decitabine plus tislelizumab: A case report.

World journal of clinical cases

相似文献

同项目论文

World journal of clinical cases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Relapsed/refractory classical Hodgkin lymphoma effectively treated with low-dose decitabine plus tislelizumab: A case report.

World journal of clinical cases

相似文献

同项目论文

World journal of clinical cases

相关期刊

检索历史清除